News | News By Subject | News by Disease News By Date | Search News

Eczema News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Regeneron (REGN), Sanofi (SNY)'s Eczema Drug Clears Hurdles in Huge Late-Stage Studies     4/1/2016
GlaxoSmithKline (GSK) Kills U.S. Part of Eczema Treatment Deal With Basilea (BSLN.SW)     1/22/2016
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Regeneron (REGN), ReGen Therapeutics Plc (RGT.L) Eczema Drug Dupilumab Gets FDA Breakthrough Therapy Designation     11/24/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Regeneron (REGN), Sanofi (SAN.PA) Begin Pivotal Phase 3 Study For Eczema Drug Dupilumab     10/20/2014
GlaxoSmithKline (GSK) Pays $227 Million for Basilea Pharmaceutica (BSLN.SW) Eczema Drug     6/12/2012
US FDA Staff Says Novartis AG and Astellas Pharma Inc. May Need Wider Eczema Caution for Kids; New Reported Cases of Cancer and Infection     3/18/2010
Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Provides Update on EpiCeram(R); Licensing Deal Delayed     8/22/2007
Intendis GmbH (SHR) Enters Market As New Dermatology Specialist     2/3/2005
Axm Pharma, Inc. (AXJ) Awarded 42 Drug Licenses By Chinese Government     11/15/2004
Acambis PLC (ACAM) Awarded Second US Government MVA Smallpox Vaccine Contract     9/30/2004
Acambis PLC (ACAM) Granted "Fast Track" Status For MVA Program     9/24/2004

News from Around the Web
Hard Water Linked To Risk Of Eczema In Infants, King's College London Study     5/18/2016
Why It Feels So Good To Scratch An Itch, Published In Proceedings Of The Entomological Society Of Washington     2/29/2016
Common Skin Disorder Linked To Surprising Health Risks, Northwestern University Study     1/20/2015
Eczema Patients More Accident Proned, Northwestern University Study     11/3/2014
Eczema May Reduce Your Skin Cancer Risk, King's College London Study     5/6/2014
Fast-Food Linked to Childhood Asthma, Eczema, University of Auckland and University of Nottingham Study     1/14/2013
Exposure to Worm Infection in the Womb May Protect Against Eczema, Study Published in Pediatric Allergy and Immunology     1/28/2011
Eczema is Double Trouble for Skin, University of Rochester Study     1/4/2011
La Jolla Institute for Allergy and Immunology Researchers Unlock Mystery Of Potentially Fatal Reaction To Smallpox Vaccine In Eczema Sufferers     5/28/2009
Water Softener Eczema Relief Hope, University of Portsmouth Study     1/13/2009
Manipulating Key Protein May Prevent Eczema, Children's Hospital Boston/Harvard Medical School Study     12/18/2008
Probiotics 'Worthless' For Eczema, Cochrane Collaboration Study     10/9/2008
Fish In Children's Diet Cuts Eczema Risk, University of Gothenburg Study     9/25/2008
Eczema in Childhood Tied to Increased Risk of Asthma Later in Life, University of Melbourne Study     8/18/2008
Cats Can Trigger Eczema in Some Infants, Say University of Copenhagen Researchers     6/25/2008

Press Releases
Second Genome Partners With King's College London To Evaluate The Influence Of The Microbiome In Landmark EAT Study     10/11/2016
PuraCap Pharmaceutical Release: DITCH THE ITCH: EpiCeram Aids In The Relief Of Eczema     9/19/2016
A*STAR Release: Skin Microbes Modulate Eczema Flares     8/1/2016
PuraCap Pharmaceutical Release: EpiCeram May Make Summertime Activities Enjoyable Again For Those With Eczema     6/17/2016
Santalis Announces Positive Results From A Study Of Pediatric Patients With Eczema (Atopic Dermatitis) Treated With The Santalia AD Over The Counter Therapy Regimen     2/22/2016
Rock Creek Pharmaceuticals Announces Targeting Of Dermatological Disease, Updated Clinical And Regulatory Strategy And Second Quarter Results     8/11/2015
Perrigo Company (PRGO) Announces The Launch Of A Generic Version Of Astellas' Protopic Ointment 0.1% And 0.03%     11/24/2014
Use of Topical Corticosteroids in Children with Eczema Does Not Have Negative Side Effects, University of Sydney Study     4/21/2011
Basilea Pharmaceutica Opens U.S. Phase III Study On Alitretinoin For The Treatment Of Severe Chronic Hand Eczema     12/17/2008
Basilea Pharmaceutica's Toctino(R) (alitretinoin) Receives Marketing Authorization in Finland     10/15/2008
Welichem Biotech Inc. (WBI.V) Completes Phase IIa Clinical Trial on Eczema     6/20/2008
Basilea Pharmaceutica Release: Canadian Regulatory Authority has Accepted New Drug Submission for Alitretinoin for Review     5/5/2008
York Pharma PLC (YRK) Release: Pre-IND Conference Requested to Enable International Phase IIb Study for Sabarep™     10/22/2007
Basilea Pharmaceutica Release: Swiss Regulatory Authority Accepts for Review the Marketing Authorization Application for Alitretinoin     10/15/2007
Basilea Pharmaceutica Announces the Submissions of Marketing Authorization Applications in the EU for Alitretinoin, an Investigational Drug for the Treatment of Severe Refractory Chronic Hand Eczema     9/11/2007

//-->